Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Dec 04, 2019

SELL
$8.75 - $12.85 $14,131 - $20,752
-1,615 Closed
0 $0
Q4 2018

Feb 21, 2019

SELL
$20.07 - $46.7 $12,042 - $28,020
-600 Reduced 27.09%
1,615 $32,000
Q3 2018

Nov 15, 2018

BUY
$41.2 - $59.85 $91,258 - $132,567
2,215 New
2,215 $101,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $138M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.